id: NEW:baclofen_prescribing_quality_to_NEW:baclofen_adverse_effects
name: Baclofen Prescribing Quality and Monitoring â†’ Severe Adverse Effects from Baclofen Treatment
from_node:
  node_id: NEW:baclofen_prescribing_quality
  node_name: Baclofen Prescribing Quality and Monitoring
to_node:
  node_id: NEW:baclofen_adverse_effects
  node_name: Severe Adverse Effects from Baclofen Treatment
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Careful monitoring of baclofen prescribing involves regular patient assessment and dose adjustment'
- 'Step 2: Adherence to prescription rules prevents inappropriate dosing and drug interactions'
- 'Step 3: Physician availability allows for timely intervention when adverse effects emerge'
- 'Step 4: Proper monitoring prevents escalation of adverse effects to severe outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'R. de Beaurepaire and Philippe Jaury 2024. "Baclofen in the treatment of alcohol
    use disorder: tailored doses matter." https://doi.org/10.1093/alcalc/agad090'
  supporting_citations:
  - Additional citations require full-text access - abstract references literature on severe adverse effects
    of baclofen
  doi: 10.1093/alcalc/agad090
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Analysis of circumstances in which severe adverse effects occur suggests that careful monitoring
  of baclofen prescribing might prevent a large majority of severe adverse effects. The paper indicates
  that many severe adverse effects could be related to physicians not following appropriate prescription
  rules and treatment monitoring protocols.
moderators:
- name: physician_adherence_to_prescription_rules
  direction: strengthens
  strength: strong
  description: Many severe adverse effects appear related to non-respect of prescription rules by physicians
structural_competency:
  equity_implications: This mechanism identifies healthcare system quality and workforce capacity as structural
    determinants of treatment safety. Inadequate physician training, high caseloads limiting monitoring
    capacity, or healthcare access barriers that prevent regular follow-up represent structural factors
    that could increase adverse effect risk. This frames treatment safety as a system-level issue rather
    than individual patient or physician failure.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.724671'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
